Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

154
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

151
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
151
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

223
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
223
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

267
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
267
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

321
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
321
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Transitions of care following acute kidney injury: a systems-based analysis.

BMC nephrology·2026
Same author

Comparing paper Letters in addition to Emailed Audit and feedback in Refining Asthma treatment to Improve clinical and environmental Results in primary care through a cluster randomised controlled trial: the CLEAR AIR study.

BMJ open respiratory research·2026
Same author

Acceptability, appropriateness and costs of a tailored implementation strategy for the national falls prevention recommendations in Norwegian municipalities-a process evaluation of the FALLPREVENT trial.

Age and ageing·2026
Same author

Defining Patient and Public Involvement and Engagement Tasks in Health Data Research: A Consensus Study.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

Experience-based co-design informed development of a toolbox to help optimise primary care support during transition from children's hospice care: HOPSCOTCH study protocol.

BMJ open·2025
Same author

Tailored implementation of national recommendations on falls prevention amongst older adults in municipalities in Norway-FALLPREVENT-a hybrid type 3 cluster-randomised trial.

Age and ageing·2025

関連する実験動画

Updated: Sep 9, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

クレアチニンクリアランス,腎臓機能低下,実践フィードバックによる処方安全性の最適化:混合方法の研究

Su I Wood1, Robbie Foy1, Paul Carder2

  • 1Division of Primary Care, Palliative Care and Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds LS2 9LN, United Kingdom.

Family practice
|September 5, 2025
PubMed
まとめ

高齢者におけるクレアチニンクリアランス (CrCl) の計算とコーディングが改善されましたが,腎機能低下における薬物誤差を減らすためにさらなるシステムサポートが必要です.

キーワード:
実現可能性調査一般的な慣行縦断研究処方する定性的な研究品質と安全性

さらに関連する動画

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

833
Direct Drug Delivery to Kidney via the Renal Artery
11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

7.5K

関連する実験動画

Last Updated: Sep 9, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

833
Direct Drug Delivery to Kidney via the Renal Artery
11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

7.5K

科学分野:

  • 高齢者医療
  • 臨床薬局
  • 医療サービス研究

背景:

  • 腎臓の機能は年齢とともに自然に低下し,薬剤の濃度が高くなると副作用の危険性が高まります.
  • クレアチニンクリアランス (CrCl) が低下した高齢患者では不適切な処方が一般的です.

研究 の 目的:

  • パフォーマンスフィードバックの介入の可行性と受け入れ性を評価する.
  • CrClの計算とコーディングの方法を改善する.
  • 高齢者における不適切な処方量を減らすために

主な方法:

  • イギリスの7つの一般診療所でCrClのコード化と処方に関する証拠に基づくパフォーマンスフィードバックを含む混合方法の研究.
  • 3つの時間点でのデータ収集,介入前の/後の評価
  • 医療従事者の観察と半構造面接を含む 制度的民族学

主要な成果:

  • 75歳以上の患者の平均CrClコードは46%から50. 4%に増加した.
  • CrClに関連した不適切な処方患者数の減少が観察されました.
  • 臨床医は,CrClの計算と薬のリコールに関する課題が継続しているにもかかわらず,フィードバックが魅力的で柔軟であることがわかりました.

結論:

  • 腎機能低下の処方薬の改善を促すことができるが,補足的なサポートが必要である.
  • システム化されたCrCl計算とコーディングは,意思決定のサポートを向上させることで,患者の安全性を高めるために不可欠です.
  • 大規模な有効性評価は実行可能であり,受け入れられるものと考えられています.